This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Halleux, C. M. Articles by Brichard, S. M. Search for Related Content PubMed PubMed Citation Articles by Halleux, C. M. Articles by Brichard, S. M.

Multihormonal Control of ob Gene Expression and Leptin Secretion from Cultured Human Visceral Adipose Tissue: Increased Responsiveness to Glucocorticoids in Obesity¹

Endocrinology and Metabolism Unit and Surgery Unit (R.D.), University of Louvain, Faculty of Medicine, UCL 5530, B-1200 Brussels, Belgium

Address all correspondence and requests for reprints to: S. M. Brichard, Unité d’Endocrinologie et Métabolisme, UCL 5530, avenue Hippocrate 55, B-1200 Brussels, Belgium.

The direct role of hormones on leptin synthesis has not yet been studied in cultured adipose cells or tissue from lean and obese subjects. Moreover, this hormonal regulation has never been addressed in human visceral fat, although this site plays a determinant role in obesity-linked disorders. In this study, we investigated the hormonal control of ob expression and leptin production in cultured visceral adipose tissue from lean and obese subjects. We more particularly focused on the interactions between glucocorticoids and insulin. We also briefly tackled the role of cAMP, which is still unknown in man. Visceral (and subcutaneous) adipose tissues from eight obese (body mass index, 41 ± 2 kg/m²) and nine nonobese (24 ± 1 kg/m²) subjects were sampled during elective abdominal surgery, and explants were cultured for up to 48 h in MEM. The addition of dexamethasone to the medium increased ob gene expression and leptin secretion in a time-dependent manner. Forty-eight hours after dexamethasone (50 nmol/L) addition, the cumulative integrated ob messenger ribonucleic acid (mRNA) and leptin responses were, respectively, approximately 5- and 4-fold higher in obese than in lean subjects. These responses closely correlated with the body mass index. The stimulatory effect of the glucocorticoid was also concentration dependent (EC₅₀ = 10 nmol/L). Although the maximal response was higher in obese than in lean subjects, the EC₅₀ values were roughly similar in both groups. Unlike dexamethasone, insulin had no direct stimulatory effect on ob gene expression and leptin secretion. Singularly, insulin even inhibited the dexamethasone-induced rise in ob mRNA and leptin release. This inhibition was observed in both lean and obese subjects, whereas the expected stimulation of insulin on glucose metabolism and the accumulation of mRNA species for the insulin-sensitive transporter GLUT4 and glyceraldehyde-3-phosphate dehydrogenase occurred in lean patients only. This inhibitory effect was already detectable at 10 nmol/L insulin and was also observed in subcutaneous fat. Although a lowering of intracellular cAMP concentrations is involved in some of the effects of insulin on adipose tissue, this cannot account for the present finding, because the addition of cAMP to the medium also decreased ob mRNA and leptin secretion (regardless of whether dexamethasone was present). In conclusion, glucocorticoids, at physiological concentrations, stimulated leptin secretion by enhancing the pretranslational machinery in human visceral fat. This effect was more pronounced in obese subjects due to a greater responsiveness of the ob gene and could contribute to the metabolic abnormalities associated with central obesity by para/endocrine actions of hyperleptinemia on adipocytes and liver. Unlike dexamethasone, insulin had no direct stimulatory effect on ob gene expression and leptin secretion, and even prevented the positive response to dexamethasone by a cAMP-independent mechanism that remained functional despite insulin resistance.

This article has been cited by other articles:

				P. M. Rogers, N. Mashtalir, M. A. Rathod, O. Dubuisson, Z. Wang, K. Dasuri, S. Babin, A. Gupta, N. Markward, W. T. Cefalu, et al. Metabolically Favorable Remodeling of Human Adipose Tissue by Human Adenovirus Type 36 Diabetes, September 1, 2008; 57(9): 2321 - 2331. [Abstract] [Full Text] [PDF]

				I. Mertens, R. V Considine, M. Van der Planken, and L. F Van Gaal Hemostasis and fibrinolysis in non-diabetic overweight and obese men and women. Is there still a role for leptin? Eur. J. Endocrinol., September 1, 2006; 155(3): 477 - 484. [Abstract] [Full Text] [PDF]

				R. Leminen, T. Raivio, S. Ranta, J. Oehler, H. von Hertzen, O. A Janne, and O. Heikinheimo Late follicular phase administration of mifepristone suppresses circulating leptin and FSH - mechanism(s) of action in emergency contraception? Eur. J. Endocrinol., March 1, 2005; 152(3): 411 - 418. [Abstract] [Full Text] [PDF]

				T. G. Ramsay and M. P. Richards Hormonal regulation of leptin and leptin receptor expression in porcine subcutaneous adipose tissue J Anim Sci, December 1, 2004; 82(12): 3486 - 3492. [Abstract] [Full Text] [PDF]

				M.-L. Delporte, S. A. El Mkadem, M. Quisquater, and S. M. Brichard Leptin treatment markedly increased plasma adiponectin but barely decreased plasma resistin of ob/ob mice Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E446 - E453. [Abstract] [Full Text] [PDF]

				K.-H. Jeong, S. Sakihara, E. P. Widmaier, and J. A. Majzoub Impaired Leptin Expression and Abnormal Response to Fasting in Corticotropin-Releasing Hormone-Deficient Mice Endocrinology, July 1, 2004; 145(7): 3174 - 3181. [Abstract] [Full Text] [PDF]

				R. Ishida-Takahashi, S. Uotani, T. Abe, M. Degawa-Yamauchi, T. Fukushima, N. Fujita, H. Sakamaki, H. Yamasaki, Y. Yamaguchi, and K. Eguchi Rapid Inhibition of Leptin Signaling by Glucocorticoids in Vitro and in Vivo J. Biol. Chem., May 7, 2004; 279(19): 19658 - 19664. [Abstract] [Full Text] [PDF]

				T. Ueland, C. Kristo, K. Godang, P. Aukrust, and J. Bollerslev Interleukin-1 Receptor Antagonist Is Associated with Fat Distribution in Endogenous Cushing's Syndrome: A Longitudinal Study J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1492 - 1496. [Abstract] [Full Text] [PDF]

				S. M. Willi, A. Kennedy, P. Wallace, E. Ganaway, N. L. Rogers, and W. T. Garvey Troglitazone Antagonizes Metabolic Effects of Glucocorticoids in Humans: Effects on Glucose Tolerance, Insulin Sensitivity, Suppression of Free Fatty Acids, and Leptin Diabetes, October 1, 2002; 51(10): 2895 - 2902. [Abstract] [Full Text] [PDF]

				K. C McCowen, P. R. Ling, C. Friel, J. Sternberg, R A. Forse, P. A Burke, and B. R Bistrian Patterns of plasma leptin and insulin concentrations in hospitalized patients after the initiation of total parenteral nutrition Am. J. Clinical Nutrition, May 1, 2002; 75(5): 931 - 935. [Abstract] [Full Text] [PDF]

				E. Charmandari, M. Weise, S. R. Bornstein, G. Eisenhofer, M. F. Keil, G. P. Chrousos, and D. P. Merke Children with Classic Congenital Adrenal Hyperplasia Have Elevated Serum Leptin Concentrations and Insulin Resistance: Potential Clinical Implications J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2114 - 2120. [Abstract] [Full Text] [PDF]

				T. S. Herrmann, M. L. Bean, T. M. Black, P. Wang, and R. A. Coleman High Glycemic Index Carbohydrate Diet Alters the Diurnal Rhythm of Leptin But Not Insulin Concentrations Experimental Biology and Medicine, December 1, 2001; 226(11): 1037 - 1044. [Abstract] [Full Text] [PDF]

				C. D. Russell, M. R. Ricci, R. E. Brolin, E. Magill, and S. K. Fried Regulation of the leptin content of obese human adipose tissue Am J Physiol Endocrinol Metab, March 1, 2001; 280(3): E399 - E404. [Abstract] [Full Text] [PDF]

				B. L. Wajchenberg Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome Endocr. Rev., December 1, 2000; 21(6): 697 - 738. [Abstract] [Full Text]

				S. K. Fried, M. R. Ricci, C. D. Russell, and B. Laferrere Regulation of Leptin Production in Humans J. Nutr., December 1, 2000; 130 (12): 3127S - 3131S. [Abstract] [Full Text] [PDF]

				L. B. Williams, R. L. Fawcett, A. S. Waechter, P. Zhang, B. E. Kogon, R. Jones, M. Inman, J. Huse, and R. V. Considine Leptin Production in Adipocytes from Morbidly Obese Subjects: Stimulation by Dexamethasone, Inhibition with Troglitazone, and Influence of Gender J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2678 - 2684. [Abstract] [Full Text]

				S. Reichlin, G. Chen, and M. Nicolson Blood to Brain Transfer of Leptin in Normal and Interleukin-1{beta}-Treated Male Rats Endocrinology, June 1, 2000; 141(6): 1951 - 1954. [Abstract] [Full Text] [PDF]

				S. S. Damjanovic, M. S. Petakov, D. Micic, J. Marinkovic, C. Dieguez, F. F. Casanueva, and V. Popovic Serum Leptin Levels in Patients with Acromegaly before and after Correction of Hypersomatotropism by Trans-Sphenoidal Surgery J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 147 - 154. [Abstract] [Full Text]

				J. S. Fisher, R. C. Hickner, S. B. Racette, E. F. Binder, M. Landt, and W. M. Kohrt Leptin Response to Insulin in Humans Is Related to the Lipolytic State of Abdominal Subcutaneous Fat J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3726 - 3731. [Abstract] [Full Text] [PDF]

				J. M. Solano and L. Jacobson Glucocorticoids reverse leptin effects on food intake and body fat in mice without increasing NPY mRNA Am J Physiol Endocrinol Metab, October 1, 1999; 277(4): E708 - E716. [Abstract] [Full Text] [PDF]

				J. Q. Purnell and M. H. Samuels Levels of Leptin during Hydrocortisone Infusions that Mimic Normal and Reversed Diurnal Cortisol Levels in Subjects with Adrenal Insufficiency J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3125 - 3128. [Abstract] [Full Text]

				G. Van den Berghe, P. Wouters, F. Weekers, S. Mohan, R. C. Baxter, J. D. Veldhuis, C. Y. Bowers, and R. Bouillon Reactivation of Pituitary Hormone Release and Metabolic Improvement by Infusion of Growth Hormone-Releasing Peptide and Thyrotropin-Releasing Hormone in Patients with Protracted Critical Illness J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1311 - 1323. [Abstract] [Full Text]